Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-28

Clinical Trial Update: Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Tanta University is evaluating the nephroprotective effects of nicorandil in type 2 diabetes mellitus, and it is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicorandil (nicorandil)

Snippet

Sponsor: Tanta University | Conditions: Type2 Diabetes Mellitus | Phase 3 | Status: RECRUITING